Pseudo collagen sales will rise through 2036, driven by conventional pseudo collagen at 58.0% of the nature segment in 2026. Liquid leads the form segment with a 52.0% share. The market is projected to reach USD 4.0 billion in 2026 and USD 8.37 billion by 2036, creating an incremental opportunity of USD 4.35 billion.